Pfizer (PFE)
(Delayed Data from NYSE)
$28.92 USD
+0.10 (0.35%)
Updated May 16, 2024 04:01 PM ET
After-Market: $29.02 +0.10 (0.35%) 7:20 PM ET
3-Hold of 5 3
B Value F Growth C Momentum D VGM
Brokerage Reports
0 items in cart
Pfizer Inc. [PFE]
Reports for Purchase
Showing records 501 - 520 ( 557 total )
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Initial Overview of Planned Animal Health Spinoff
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Cost Reduction Leads to Higher Second Quarter EPS
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
1Q Results Impacted by the Lipitor Patent Expiration. Nestle to Purchase Nutrition Unit
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Specialty Pharmaceuticals Short Interest Analysis
Provider: AURIGA USA
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Griffin Securities Updates Coverage on Lpath, Inc. (LPTN)
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Overall near term outlook remains quite encouraging despite slight downward revision to anagements CY12 guidance & Lipitors patent expiry.
Provider: FIRST GLOBAL
Analyst: THOMAS K